Manuscript
Manuscript
Manuscript
[email protected]
3 Institute for Drug-Herbal Medicine-Excipient Research and Development, University of Nigeria, Nsukka,
Nigeria; [email protected]
* Correspondence: [email protected]; Tel.: +234-8034627630
† Presented at the 1st International e-Conference on Antioxidants in Health and Disease, 01–15 December
Abstract: Background: Oxidative stress has been implicated in many chronic diseases and the use
of natural antioxidants has been suggested to be beneficial in the prevention and management of
some chronic diseases. Deep Root® herbal mixture (DRHM) is a branded Nigerian polyherbal drug
composed of Cymbopogon citratus (17%), Carica papaya leaves (16%), Magnifera indica bark (15%),
Moringa oleifera leaves (14%), Citrus limonia (12%), Psidium guajava (11%), Zingiber officinale root (9%)
and Allium sativium (6%). The potential of DRHM in modulating hydrogen peroxide (H2O2)-induced
oxidative stress in rats was assessed in this study. Methods: Healthy Wistar rats were divided into
six groups (n = 5) with group 1 serving as normal control while groups 2–6 were intoxicated (3
mL/kg b.w of 5% v/v of H2O2, i.p). Group 2 served as H2O2 control, groups 3–5 received 1, 2 and 3
mL/kg/d b.w. p.o of DRHM, respectively while group 6 was given silymarin (100 mg/kg/d. b.w. p.o)
for 14 days. Results: H2O2 elevated aspartate and alanine aminotransferases activities, and
malondialdehyde and total bilirubin levels (p < 0.05). Conversely, H2O2 decreased superoxide
dismutase, catalase and glutathione peroxidase activities, and antioxidant vitamins and reduced
glutathione levels (p < 0.05). However, DRHM dose-dependently attenuated oxidative damage to
hepatic tissues likely by enhancing antioxidant defense system. The polyherbal drug was shown to
be tolerable up to 10 mL/kg. b.w. dose. Conclusion: DRHM has hepatoprotective, antioxidant and
anti-lipid peroxidation properties that may be attributed to its phytoconstituents.
1. Introduction
The excessive generation of free radicals beyond the level in which the natural antioxidant
defence of the body can neutralize results in oxidative stress is linked with pathogenesis of
cardiovascular diseases, ageing and diabetes [1]. These damages usually occur via inactivation of
important metabolic enzymes and damages to vital cellular macromolecules, often resulting in
devastating consequences [2]. The liver helps in the detoxification and removal of xenobiotics, some
The 1st International Electronic Conference on Antioxidants in Health and Disease, 1–15 December 2020
The 1st International Electronic Conference on Antioxidants in Health and Disease, 1–15 December 2020
of which are potentially toxic [3]. This renders the liver susceptible to injury or impairment of its
functions in the presence of toxicants. The burden of liver diseases is high because damage to this
important metabolic organ has serious implications to the entire health and wellbeing [4]. One major
mechanism of xenobiotic-induced liver damage is radical species-mediated, leading to oxidative
damage to the hepatocytes. Hepatotoxicity is usually characterized by necrosis of hepatocytes,
elevation in lipid peroxidation and decrease in reduced glutathione (GSH) concentration. The serum
bilirubin and lipid profile and activities of transaminases and alkaline phosphatase are increased
during liver damage [5]. In addition, supplementation with antioxidants-rich agents as a remedy to
radical species-related assaults on cells has been suggested [6,7]. The use of herbal remedies all over
the world for the management of diseases is increasing [8,9]. There is a widespread perception that
herbal drugs have little or no side effect [10], making them a first consideration in some African and
Asian populations for treating many diseases [11]. Traditional remedies are usually made up of only
one part of the plant. However, accumulation of therapeutic experience and the search for improved
health outcomes by herbal practitioners over time have resulted in a shift from the use single plant
or plant parts to combining different plants or plant parts for enhanced therapeutic potentials [12].
This involves the use of specific proportions of leaves, stem, seeds and roots of different plants in
water, alcohol or other non-toxic solvents. It is believed that the active principles in these plants work
synergistically or in combination to produce enhanced therapeutic effect [13]. Nigerian drug stores
are enriched with several branded polyherbal formulations. One of such polyherbal formulations
which have flooded Nigerian drug market is DRHM, a product of FESCO Herbal Mixtures Nigeria
Limited. According to the manufacturer, the drug is composed of extracts of Cymbopogon citratus
(17%), Carica papaya leaves (16%), Magnifera indica bark (15%), Moringa oleifera leaves (14%), Citrus
limonia (12%), Psidium guajava (11%), Zingiber officinale root (9%) and Allium sativium (6%) blended in
water. It is acclaimed by the manufacturer to be a potent detoxifier and blood boost, and also effective
in the management of disease conditions such as malaria and typhoid, hepatitis, gonorrhea, fibroid,
syphilis, E. coli, menstrual problems, low sperm count, among others. The effects of Deep Root®
herbal mixture on H2O2-induced hematological and biochemical aberrations in rats were assessed in
this study.
2. Experiments
Phytochemical analyses of Deep Root® herbal mixture: The method of Harborne [14] and
Trease and Evans [15] were used for the detection and quantification of the phytochemical
constituents of DRHM.
Determination of acute toxicity profile of Deep Root® herbal mixture: This was done using
twenty healthy male Wistar mice of body weight range 25–30 g. They were sourced from the
Department of Zoology and Environmental Biology, University of Nigeria, Nsukka. After 7 days of
acclimatization to laboratory environment, the mice were fasted overnight and the body weights
were measured, thereafter, they were then divided into four groups of five mice each. Mice in groups
1–4 were treated with 1, 3, 5 and 10 mL/kg b.w. of DRHM, respectively. The experimental mice were
monitored for 24 h for neurological, behavioural and morphological signs of toxicity. Body weights
of the mice were measured 24 h-post DRHM-treatment to evaluate if there is any significant body
weight change.
Study design for animal study: Thirty healthy male Wistar albino rats (180–200 g) used for this
study were obtained from the Faculty of Veterinary Medicine, University of Nigeria, Nsukka. They
were maintained under standard husbandry conditions of light (12 h) and darkness (12 h), room
temperature of 26 ± 2 °C, and with free access to commercial rat chow (Vital Grower Feed Nigerian
Limited) and portable water ad libitum. The animals were ethically handled according to standard
institutional, national and international protocols. After acclimatization, the experimental rats were
divided into 6 groups of 5 rats each: Group 1 served as normal control (NC). Group 2–6 were
intoxicated by single intraperitoneal administration of 3 mL/kg b.w of 5% v/v of H2O2 on day 0; group
2 that served as hydrogen peroxide (H2O2) control (HC) was not treated. Groups 3–6 received 1, 2
2
The 1st International Electronic Conference on Antioxidants in Health and Disease, 1–15 December 2020
and 3 mL/kg/d b.w. of DRHM while group 6 received 100 mg/kg/d b.w. of silymarin (Livergad Forte®,
Laborate Pharmaceuticals, India) p.o. from days 1 to 14. The rats were sacrificed under mild
chloroform anaesthesia on day 15. An overnight fasting blood sample was collected from each rat
through the jugular veins in anticoagulated bottle as well as plain tube. Samples collected in
anticoagulated tubes were subjected to hematological analyses while samples collected in plain tubes
were allowed to clot for 15 min and thereafter centrifuged at 3,000 g for 10 min. Serum from each
sample was subjected to biochemical analyses of liver, lipid peroxidation and antioxidant status.
Determination of biochemical parameters: The parameters evaluated and methods used were:
Serum activities of aspartate (AST) and alanine (ALT) aminotransferases [16], catalase (CAT) [17],
glutathione peroxidase (GPx) [18] and superoxide dismutase (SOD) [19], serum concentrations of
total bilirubin [20], reduced glutathione [21], malondialdehyde (MDA) [22], and vitamins A, C and E
[23,24].
Statistical analysis: Statistical analysis of primary laboratory data was performed by one-way
ANOVA using statistical products and service solutions (SPSS), version 18 and the results presented
as mean ± standard deviation (SD) in Tables. Test of significance were set at p < 0.05.
3
The 1st International Electronic Conference on Antioxidants in Health and Disease, 1–15 December 2020
treated with M. oleifera leaves, one of the components of the polyherbal formulation. Bilirubin is a
breakdown product of hemoglobin in liver cells, spleen and bone marrow. As the liver becomes
stressed, serum bilirubin level becomes elevated, indicating hepatic damage or bile duct damage
within the liver itself [33]. In this study, treatment of intoxicated rats with DRHM significantly (p <
0.05) reduced the total bilirubin level when compared to intoxicated and untreated group. Justin et
al. [26] reported that plant secondary metabolites are effective in protecting against oxidative stress-
related diseases. The observed improvement in hepatic function could therefore, be attributed to the
phytochemicals present in DRHM.
3.4. Effect of DRHM on Antioxidant and Lipid Peroxidation Status of H2O2-Intoxicated Rats
Malondialdehyde (MDA) is a common biomarker of lipid peroxidation status [32,33]. Elevation
in MDA level indicates the degree of injury in the hepatocytes [36,37]. It was observed that MDA
level increased in serum of HC when compared with NC. Meanwhile, treatment of intoxicated rats
with DRHM significantly (p < 0.05) reversed these changes (Table 2). This suggests that the
mechanism of hepato-curative effect of DRHM seen above is probably due to its anti-lipid
peroxidation effect. SOD, CAT and GPx are part of the hepatic antioxidant defense system that
contributes to the regulation oxido-reductive homeostasis and mitigation of oxidative attacks on cells
[38]. DRHM significantly (p < 0.05) increased SOD, CAT, and GPx activities in the treated rats (Table
2). H2O2 control (HC) had a significantly (p < 0.05) lower GSH concentration than NC. Meanwhile,
treatment of intoxicated rats with graded doses of DRHM significantly (p < 0.05) increased the GSH
concentration compared with HC, in a manner comparable to that of intoxicated rats treated with
silymarin (Table 2). The GSH is an intracellular antioxidant which is also a co-factor to GPx and
glutathione reductase. A low GSH concentration exacerbates oxidative assaults, resulting in
increased membrane and cell damage. The lower GSH level observed in the intoxicated and
untreated rats when compared with normal control might be responsible for the reduced GPx
activity. Similarly, a decrease in CAT activity leads to reduced H2O2 decomposition. H2O2 reacts with
free iron leading to production of hydroxyl radical that is very toxic to the cells [39]. Treatment of
intoxicated rats with DRHM significantly (p < 0.05) increased the GSH concentration and this could
be responsible for the overall improvement in antioxidant status of the treated rats.
Table 2. Effect of DRHM on antioxidant and lipid peroxidation status of H2O2-intoxicated rats.
4
The 1st International Electronic Conference on Antioxidants in Health and Disease, 1–15 December 2020
Data are mean ± standard deviation (SD) (n = 5). Values with different superscripts in a column are
significantly different at p < 0.05. SOD = superoxide dismutase; GPx = glutathione peroxidase; CAT =
catalase, GSH = reduced glutathione; MDA = malondialdehyde.
Table 3. Effect of DRHM on reduced glutathione and antioxidant vitamins concentrations of H2O2-
intoxicated rats.
4. Conclusions
The results of the present study support the existing knowledge that hydrogen peroxide (H2O2)
induces cellular oxidative stress via enhancing the production and attack of free radicals on cells and
weakening of body’s antioxidant defense system. The results further added that treatment of H2O2-
intoxicated rats with Deep Root® herbal mixture (DRHM) reverses the associated biochemical
aberrations. The above beneficial bioactivities might be attributed to wide varieties of phytochemicals
detected in DRHM. This makes the herbal drug a potential candidate for the treatment/management
of oxidative-stress related conditions. The polyherbal formulation was not toxic up to 10 mL/kg b.w.
dose. However, further studies are needed to evaluate the long-term effects of using this polyherbal
formulation.
Author Contributions: I.U.O.; C.C.C. and J.C.N. conceived and designed the experiments; I.U.O. and
C.C.C.performed the experiments; I.U.O.; A.P.O.; E.C.A. and C.C.C. analyzed the data; J.C.N. and E.C.A.
contributed reagents/materials/analysis tools; I.U.O., J.C.N., C.C.C., A.P.O. and C.C.C. wrote the paper.
5
The 1st International Electronic Conference on Antioxidants in Health and Disease, 1–15 December 2020
Abbreviations
The following abbreviations are used in this manuscript:
DRHM: Deep Root® herbal mixture;
SOD: superoxide dismutase;
GPx: glutathione peroxidase;
CAT: catalase;
GSH: reduced glutathione;
MDA: malondialdehyde;
AST: Aspartate aminotransferase;
ALT: alanine aminotransferase
References
1. Yaribeygi, H.; Mohammadi, M.T.; Sahebkar, A. Crocin potentiates antioxidant defense system and
improves oxidative damage in liver tissue in diabetic rats. Biomed. Pharmacother. 2008, 98, 333–337.
2. Hossain, U.S.; Islam, H.M.; Taibur, R. Oxidative stress and human health. Adv. Biosci. Biotechnol. 2012, 3,
997–1019.
3. Larrey, D. Drug-induced liver diseases. J. Hepatol. 2000, 32, 77–88.
4. Lopez, A.M.; Hendrickson, R.G. Toxin-induced hepatic injury. Emerg. Med. Clin. N. Am. 2014, 32, 103–125.
5. Khaki, K.F.; Rahbani, N.M.; Yaghoubi, A.R. Study of antioxidant enzymes, lipid peroxidations, lipid profile
and immunologic factor. Int. J. Biomed. Res. 2012, 1, 147–152.
6. Kelkar, G.; Subhadra, K.; Chengappa, R.K. Effect of antioxidant supplementation on hematological
parameters, oxidative stress and performance of Indian athletes. J. Hum. Ecol. 2008, 24, 209–213.
7. Jahan, S.; Fatima, A.; Alam, I.; Ullah, A.; Rehman, H.; Afsar, T.; Almajwal, A.; Razak, S. Effects of dietary
supplements on selected hematological and biochemical parameters of Pakistani athletes. BMC Nutr. 2018,
4, 41.
8. Ndhlala, A.R.; Stafford, G.I.; Finnie, J.F.; Van Staden, J. Commercial herbal preparations in KwaZulu-Natal,
South Africa: The urban face of traditional medicine. S. Afr. J. Bot. 2011, 77, 830–843.
9. Anionye, J.C.; Onyeneke, E.C.; Eze, G.I.; Edosa, R.O.; Agu, K.C.; Omorowa, E.F.; Oghagbon, E.S. Evaluation
of the effects of Yoyo bitters on albino rats. IDOSR J. Appl. Sci. 2017, 2, 1–24.
10. Onyeaghala, A.A.; Omotosho, I.O.; Shivashankara, A.R. Cytotoxicity of various fractions of compounds
extracted from Yoyo bitters on human cervical cancer cells. Eur. J. Med. Plants 2015, 7, 46–58.
11. Philip, F.B.; Chris, A.A.; John, A.A.; Israel, E.J. Survey on the pharmaceutical quality of herbal medicines
sold in Nigeria. J. Appl. Pharm. Sci. 2015, 5, 97–103.
12. Kong, D.E.; Li, X.J.; Zhang, H.Y. Where is the hope for drug discovery? Let history tell the future. Drug
Discov. Today 2009, 14, 115–119.
13. Aguiyi, E.N. The effects of Yoyo Bitters and Swedish Bitters on Kidney Cholesterol in Albino Rats.
Bachelor’s Thesis, University of Agriculture, Abeokuta, Nigeria, 2010.
14. Harborne, J.B. Phytochemical Methods; Chapman and Hall Limited: London, UK, 1973; pp. 49–88.
15. Trease, G.E.; Evans, W.C. Pharmacognosy, 13th ed.; Bailliere-Tyndall Ltd.: London, UK, 1989; pp. 42–44, 221–
229, 246–249, 404-306, 331–32, 391–393.
16. Reitman, S.; Frankel, S. A colorimetric method for the determination of serum glutamic oxaloacetic and
glutamic pyruvic transaminase. Am. J. Clin. Pathol. 1957, 28, 56–63.
17. Aebi, H. Catalase in vitro. Methods Enzymol. 1984, 105, 121–126.
18. Paglia, D.E.; Valentine, W.N. Studies on the quantitative and qualitative characterization of erythrocyte
glutathione peroxidase. J. Lab. Clin Med. 1967, 70, 158–169.
19. Fridovich, I. Superoxide dismutase: An adaptation to a paramagnetic gas. J. Biol Chem. 1989, 264, 7761–
7764.
20. Jendrassik, J.; Grof, P. In vitro determination of total and direct bilirubin in serum or plasma. Biochemistry
1976, 6, 269–275.
21. Habig, W.H.; Pabst, M.J.; Jakoby, W.B. Glutathione-S-transferases. The first enzymatic step in mercapturic
acid formation. J. Biol. Chem. 1974, 249, 7130–7139.
6
The 1st International Electronic Conference on Antioxidants in Health and Disease, 1–15 December 2020
22. Wallin, B.; Rosengren, B.; Shertzer, H.G.; Camejo, G. Lipoprotein oxidation and measuring of thiobarbituric
acid reacting substances (TBARS) formation in a single microtiter plate: Its use for evaluation of
antioxidants. Anal. Biochem. 1993, 208, 10–15.
23. Goodhart, R.S.; Shils, M.E. Modern Nutrition in Health and Disease Dictotherapy; Lea and Febiger:
Beckenham, UK, 1973; pp. 245–253.
24. Desai, I.D. Vitamin E analysis methods for animal tissues. Methods Enzymol. 1984, 105, 138–147.
25. [25]. Abhishek, G.; Dharmendra, S.; Jyoti, S.; Mamta, S.; Rajeev, N. Phytochemistry of medicinal plants. J.
Pharmacogn. Phytochem. 2013, 1, 168–182.
26. Justin, N.; Kabera, E.; Semena, A.; Mussa, R.; Xin, H. Plant secondary metabolites, biosynthesis,
classification, function and pharmacological properties. J. Pharm. Pharmacol. 2014, 2, 377–392.
27. Khawaya, T.M.; Tahira, M.; Ikram, U.I. Moringa oleifera: A natural gift—A review. J. Pharm. Sci. Res. 2010, 2,
775–781.
28. Capasso, A. Antioxidant action and therapeutic efficacy of Allium sativum. Biomolecules 2013, 18, 690–700.
29. Ghosh, A.K. Zingiber officinale: A natural gold. Int. J. Pharm. Biosci. 2011, 2, 283–294.
30. Ahmad, F.A.; Muhammad, D.I.; Saie, B.K. Health benefits of Moringa oleifera. Asian Pac. J. Cancer Prevent.
2014, 15, 8571–8576.
31. Navarro, V.J.; Senior, J.R. Drug-related hepatotoxicity. N. Engl. J. Med. 2006, 354, 731–739.
32. Varsha, J.; Vilasrao, K.; Tejashree, S. Roles of Moringa oleifera in medicine. World J. Pharm. Pharm. Sci. 2014,
4, 375–385.
33. Ochei, J.; Kolhatkar, A. Medical Laboratory Sciences: Theory and Practice; Tata McGraw Hill: New York, NY,
USA, 2008; pp. 663–665.
34. Mistry, S.; Dutt, K.R.; Jena, J. Protective effect of Sida cordata leaf extract against CCl4 induced acute liver
toxicity in rats. Asian Pac. J. Trop. Med. 2013, 6, 280–284.
35. Messarah, M.; Saoudi, M.; Boumendjel, A.; Kadeche, L.; Boulakoud, M.S.; El Feki, A. Green tea extract
alleviates arsenic-induced biochemical toxicity and lipid peroxidation in rats. Toxicol. Ind. Health 2013, 29,
349–359.
36. Yuan, L.P.; Chena, F.H.; Ling, L.; Doub, P.F.; Bob, H.; Zhonga, M.M. Protective effects of total flavonoids
of Bidenspilosa L. (TFB) on animal liver injury and liver fibrosis. J. Ethnopharmacol. 2008, 116, 539–546.
37. Djeffal, A.; Messarah, M.; Boumendjel, A.; Kadeche, L.; El Feki, A. Protective effects of vitamin C and
selenium supplementation on methomyl-induced tissue oxidative stress in adult rats. Toxicol. Ind. Health
2015, 31, 31–43.
38. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima,
M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome.
J. Clin. Investig. 2017, 114, 1752–1761.
39. Mariusz, G.; Slawomir, K. A study of free radical chemistry; their role and pathophysiological significance.
Acta Biochem. Pol. 2013, 60, 1–16.
40. Singh, R.P.; Sharad, S.S.; Kapur, S. Free radicals and oxidative stress in neurodegenerative diseases:
Relevance of dietary antioxidants. J. Indian Acad. Clin. Med. 2004, 5, 218–225.
41. Farbstein, D.; Koza-blickstein, A.; Levy, A.P. Antioxidant vitamins and their use in preventing
cardiovascular disease. Molecules 2010, 15, 8098–8110.
42. Farooq, F.; Rai, M.; Tiwai, A.; Khan, A.A.; Farooq, A. Medical properties of Moringa oleifera: An overview
of promising healer. J. Med. Plants Res. 2012, 6, 4368–4374.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional
affiliations.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).